Publication Name	World Journal of Gastroenterology
Manuscript ID	8097
Country

Received	2013-12-15 17:29
Peer-Review Started	2013-12-16 11:11
To Make the First Decision	2014-01-09 11:55
Return for Revision	2014-01-12 14:14
Revised	2014-01-28 09:53
Second Decision	2014-04-03 10:08
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-04-03 11:34
Articles in Press	2014-05-23 09:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-09-03 16:08
Publish the Manuscript Online	2014-09-19 19:25

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Resection of hepatitis B virus-related hepatocellular carcinoma: Evolving strategies and emerging therapies to improve outcome
Manuscript Source	Invited Manuscript
All Author List	Gar-Yang Chau
Funding Agency and Grant Number
Corresponding Author	Gar-Yang Chau, MD, MPH, Professor of Surgery, Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, and School of Medicine, National Yang-Ming University, Shih-pai, Taipei 112, Taiwan. gychau@vghtpe.gov.tw
Key Words	Hepatocellular carcinoma; Hepatitis B virus; Hepatic resection; Outcome; Adjuvant therapy
Core Tip	Chronic hepatitis B virus infection is the main cause of hepatocellular carcinoma (HCC). Liver resection is currently the mainstay of treatment. However, the postresectional tumor recurrence rates remain high. There is an ever-increasing demand on surgeons to perform curative liver resection in HCC, with the hope of avoiding tumor recurrences. The author presents a review of the recently evolving strategies and emerging therapies to improve patient outcomes, including a policy of accurate preoperative staging, adequate resection, intensive postoperative follow-up, and early initiation of effective adjuvant therapy, with particular reference to the current status of adjuvant therapies in HCC patients after liver resection.
Publish Date	2014-09-19 19:25
Citation	Chau GY. Resection of hepatitis b virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome. World J Gastroenterol 2014; 20(35): 12473-12484
URL	http://www.wjgnet.com/1007-9327/full/v20/i35/12473.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i35.12473

Full Article (PDF)	WJG-20-12473.pdf
Full Article (Word)	WJG-20-12473.doc
Manuscript File	8097-Review.docx
Answering Reviewers	8097-Answering reviewers.pdf
Copyright License Agreement	8097-Copyright_Assisgnment.pdf
Non-Native Speakers of English Editing Certificate	8097-Language certificate.pdf
Peer-review Report	8097-Peer review(s).pdf
Scientific Editor Work List	8097-Scientific editor work list.doc